$VTGN

VistaGen Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$3.6 ▼-4.255%

Delayed Price

VOLUME

197,080

DAY RANGE

-

52 WEEK

1.62 - 24.71

Join Discuss about VTGN with like-minded investors

profile
@dros #droscrew
recently

RECAP 7/8 Unusual Calls: $DISH Jul 19 C $CLVS Jul 3 C $WDC Sep 60 C $MULN Jul 1.5 C $KSS Aug 42.5 C $SNAP Jan-24 50 C $VTGN Nov 1/2.5 C Spd $BIRD Dec 7.5 C $TECK Aug 30 C $OXY Jan 70 C $DDOG Jan 130 C $ARVL Sep 2.5 C

100 Replies 15 👍 12 🔥

profile
@dros #droscrew
recently

RECAP 6/27 Unusual Calls $BITO Jun30 14 C $TQQQ Jul08 35 C $DISH Jul08 20 C $HOOD Jul01 9 C $EWG Jul 24.75 C $ASHR Jul 35 C $LAZR Aug 10 C $C Sep 55/62.5 C Spd $RBLX Oct 75 C $CRK Jul 15 C $VAL Aug 50/60 C Spd $MRK Jul01 96 C $CHPT Jul08 16/19 C Spd $SABR Aug 8 C $DAL Aug 35 C $WOW Aug 17.5 C $VTGN Aug 1/2.5 C Spd $DNA Aug 3.5 C $HOOD Jan 20 C $FXI Jul 35 C $KRE Dec 73 C

129 Replies 8 👍 6 🔥

Key Metrics

Market Cap

101.61 M

Beta

4.67

Avg. Volume

610.44 K

Shares Outstanding

27.02 M

Yield

0%

Public Float

0

Next Earnings Date

2024-02-06

Next Dividend Date

Company Information

we have developed a versatile stem cell technology platform based on the controlled differentiation of human pluripotent stem cells into mature, non-transformed, human cells which can be used to create novel bioassay systems for predictive toxicology, drug metabolism screening, drug discovery, drug rescue and cell therapy. we believe our stem cell technology platform, human clinical trials in a test tube™, can provide clinically relevant predictions of potential toxicity and metabolism issues of promising new drug candidates long before they are ever tested in humans.

Website:

HQ: ,

Related News